Introduction
Radiotherapy is, besides surgery, the most important treatment option in clinical oncology. It is used with both curative and palliative intention, either solely or in combination with surgery and chemotherapy. The majority of radiotherapy patients is treated with high energetic photon beams. The radiation is produced by a linear accelerator and delivered to the patient by several beams coming from different directions (see figure 1 ). The goal of conformal radiation therapy is to deliver a high and homogeneous dose to the tumor volumes while limiting the side-effects of this treatment. Aside from the risk of damaging critical healthy organs, there is also the risk of secondary cancer [3] . To better control the radiation received by the patient, several different methods have evolved to modulate the beam intensities from the gantry. First there was the open field technique where only the shape of each beam is adapted to the target volume. The intensity of the radiation throughout the beam's cross section is uniform or only modified by the use of pre-fabricated wedge filters. Over time the hardware improved and it was possible to fully modulate the intensity of each beam. Intensity modulated radiation therapy (IMRT) is realized by multi-leaf collimators (MLCs) (see figure 2) . Parts of the beam surface are uncovered for individually chosen opening times while the rest of the area is covered by the leaves. The intensities emitted from these beams are described by intensity maps such as the one depicted on the left side of figure 1. One method to apply these intensity maps is to turn off the beam energy while the leaves of the MLC move. This is called static delivery. The alternative where the beam stays on during the application of one intensity map is the dynamic delivery. While both . The square opening is partially covered by leafs, each of which can be individually moved. Picture taken from [9] . are used in practice, the considerations in this paper are only relevant for the static method.
Finding suitable intensity maps given a set of beam directions and corresponding couch angles is the treatment planning problem in IMRT. We demand that the directions and couch angles are fixed because to find optimal directions is a global optimization problem. The variables of the treatment planning problem are therefore the intensity maps. Usually, the cross section of the beam is discretized on a regular grid with a resolution determined by the width of the collimator leaves. This corresponds to a discretization to fields of size typically less than or equal to 10 x 10 mm. Each small field is called a beamlet. The number of variables in a typical treatment planning problem with five to seven beam directions corresponds to several hundred beamlets. The aim to destroy cancerous cells while sparing healthy structures naturally lends itself to the formulation of a multicriteria optimization problem in which the dose in each tumor and each healthy structure is assessed with separate objective functions [15] . A decision-support system to select a treatment plan from the Pareto frontier of such a multicriteria approach is described in detail in [6] .
This multicriteria approach provides control over the trade-off between overdosing healthy structures and destroying cancerous cells. However, it does not consider the time needed to deliver the intensity maps using an MLC. The risks of treatment errors due to patient movement and too much exposure to radiation increase with treatment time. An objective function that provides some control over this aspect was introduced in [2] . However, adding an objective function to the treatment planning problem also increases its complexity. When faced with a complicated case with many healthy structures close to the tumor volumes, significant computation time might be saved by disregarding the treatment time during optimization. Instead, the intensity maps are transformed before they are translated into MLC leaf configurations and delivered to the patient.
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One such transformation is to reduce the number of different intensity levels in an intensity map. Experiments show that if the number of intensity levels decreases, the number of apertures can be expected to decrease also [5, 14] . This stratification can, for example, be performed for a given intensity map as shown in figure 3 . However, this requires a solution to the planning problem. A reduction of the num- ber of variables in the treatment planning problem by requiring that some beamlets have the same intensity value is the a priori counterpart to stratification. The benefit of a priori stratification are simpler calculations by a reduction in the number of variables and a reduction in the number of apertures and a shorter treatment time because the plans are simpler. The cost is a limited control over the dose in the patient's body. The trade-off between the consequences of stratification must be carefully evaluated when planning a therapy.
Some attempts have been made to modify optimization algorithms for the treatment planning problem to reduce the number of apertures resulting from sequencing. Most notably, Alber and Nüsslin [1] have proposed an operator that modifies the solution at every fixed iterations during the optimization. This operator sets neighboring beamlets to equal intensities, which are then grouped to apertures. The intensity corresponding to all created apertures are then additional variables in the optimization. A different approach was taken by Keller-Reichenbecher et al [5] . Here, the solution is stratified to a small number of intensity levels every fixed number of iterations. Although the results presented in the latter approach indicate that the methods performs quite well, it remains a heuristic approach and does not in general converge to an optimal solution.
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To address the goal of a short treatment time, the new objective function in [2] and the approach in [1] increased the complexity of the problem. The method in [5] retained the complexity of the original planning problem, but it is a heuristic. In this paper, we describe a method to first reduce the number of variables of the planning problem to a very small number. During the solver iterations, we adaptively add more degrees of freedom to refine the solution until it is acceptable. The planner may set a limit to the number of variables that are used and can control the resulting complexity of the intensity maps. By setting this limit equal to the number of variables in the treatment planning problem, this approach produces optimal solutions. Moreover, it is numerically verified that the adaptive refinement of the problem formulation based on clinically meaningful guidelines has a positive effect on the convergence of a solution mechanism.
In chapter 2 we motivate the idea of aggregating the variables by the dose computation necessary in IMRT planning. We also justify the use of a heuristic clustering procedure. In chapter 3 we introduce the clustering technique and demonstrate its applicability on an artificial example and on a clinical prostate case. We also specify a treatment planning problem formulation for the prostate case which will serve as an illustration for the techniques later. In chapter 4, the refinement strategy is proposed and carried out for the prostate case. Numerical results about the solver progress and the comparison of the solutions obtained by the aggregation and refinement and the original formulation are made. Chapter 5 concludes this paper.
Dose computation and variable aggregation
As it was mentioned, the intensity maps are discretized on a regular grid to a set of beamlets. The patient's body is also discretized into small volume elements called voxels to simplify the computation of the dose received by each small volume part. The slices of the CT scan imply a natural dissection in the z-direction. Together with a further sectioning of the x-y plane, the voxels typically are of dimensions of a few millimeters. As a consequences of these discretizations and the superposition principle of dose deposits in photon therapy, the dose distribution over the voxels can be calculated by the matrix multiplication
where d is the m-dimensional vector of dose values for all voxels, the matrix P is the dose information matrix, and the n-dimensional vector x are the intensities of the beamlets over all beams, written as one column vector. The entry p ji of the dose information matrix represents the contribution of the ith beamlet to the absorbed dose in the jth voxel under unit intensity. There are several methods to estimate these values. They might be calculated using the pencil beam approach, a superposition algorithm, or some Monte Carlo method. In this paper we do not
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5 discuss this important issue -the interested reader is referred to the books by Webb [12, 13] . We assume that P is given in some satisfactory way. Note that the rows of P correspond to the voxels and the columns to the beamlets. Therefore, P typically has a little over one million rows and several hundred columns. Moreover, the matrix is sparse -often only 10% of the entries are positive. The reason is that one beamlet only hits a small portion of voxels compared to the entire volume. The dose calculation takes significant time in an iterative optimization algorithm to determine the intensity maps -even when techniques to exploit the sparsity of P are used. Further, as MLC hardware becomes even more sophisticated, the leaves will become thinner, and the number of columns of P will increase in the future.
A numeric technique to reduce the number of rows of P using an adaptive clustering method was presented in [8] . Neighboring voxels belonging to the same organs or tumors are treated as groups if their dose deposits are "similar". The optimization is carried out on these clusters of voxels with a dose information matrix that has relatively few rows. The largest errors due to the clustering are identified and the clusters broken up to attain a refined description of the body. This iteration between optimization and refinement continues until the clustering error is below a threshold. In this paper, we focus on the aggregation of variables, so we are interested in reducing the number of columns of P.
To reduce the degrees of freedom of the treatment planning problem means to constrain some of the beamlets to have equal intensity values. Imagine that the beamlets are partitioned into L groups B 1 , . . . , B L , and each group of beamlets has their own intensity b . Thus, x i = b for all beamlets i belonging to group B b . This means, the dose calculation (1) can be written as
Aggregating the variables in the treatment planning problem effectively reduces the size of P by summing up all columns that correspond to beamlets with identical intensity values. To code the allocation of beamlets to same groups, we introduce the n × L matrix A with entries
The dose calculation (2) can then be written as d = P · A · , with as the vector of all group intensities. The "small dose information matrix" P · A makes the computation of d much faster if L n. If the number of different intensity levels L is fixed, we can formulate the allocation problem to find A as an optimization problem to minimize a metric that describes the error due to the aggregation. In other words, right-multiplying A to P should keep the norm d − P · A · q for q ≥ 1 and any given dose d and intensities small.
Problem 2.1 (Allocation problem)
Given a dose distribution d, a dose information matrix P and a set of group intensities , find an allocation A that approximates the resulting evaluation of dose distribution as close as possible under the norm · q for q ≥ 1:
Note that the constraints in Problem 2.1 produce a partition of the beamlets. Unfortunately, the Allocation problem is NP-hard.
To see that the Allocation problem is hard, we reduce PARTITION to an instance of Problem 2.1. Let k 1 , . . . , k n be a set of positive integers and g = 1 2
n i=1 k i . PARTITION asks if there is a partition of the integers into subsets S 1 and S 2 such that i∈S j k i = g for j = 1, 2. Now consider the following Allocation problem:
If the optimal objective function value (3) is 0 for any q ≥ 1, then PARTITION is answered with yes, and no otherwise. This is the Allocation problem with d = g g T , P with the set of integers k 1 , . . . , k n as row vectors, and the group intensities given by 1, the vector of all 1s. This result discourages a search for the optimal aggregation. The alternative is to develop a method that produces solutions of acceptable quality.
Note that if two columns of P are "similar", meaning the positive entries hit voxels belonging to the same structures with similar contributions, it may be expected that the optimal intensities corresponding to the two beamlets are similar as well. That is, we would like to group together those beamlets with similar impact on the dose distribution d. Grouping similar objects is achieved by clustering methods [4] . In the following chapter, we derive a clustering algorithm to group similar beamlets.
Beamlet clustering and implications
The ingredients for a clustering method are a measure of similarity between objects and between objects and clusters, and an algorithm to group the objects based on 7 these similarities. Instead of maximizing the similarity between objects inside a cluster, the dissimilarity could be minimized. A simple measure of dissimilarity of objects that are characterized by a vector of real numbers are the distance metrics
for q ≥ 1. For q = 1, (4) is the rectilinear or Manhattan metric, and for q = 2, (4) becomes the Euclidean metric. We will use q = 2 and take "dist" without the subscript q to mean the Euclidean metric from here on. A cluster will be represented by an average over all columns that are grouped to it. This representative is given by
where P i is the ith column of P.
A first attempt to characterize the beamlets might be to use the columns of P. There are, however, two disadvantages associated with taking the entire "information" of each beamlet. First, evaluating the distance (4) between two beamlets takes a long time because potentially many entries have to be compared. This calculation becomes even more tedious as clusters grow in size because a vector of averages over sparse columns is in general less sparse. The other disadvantage is that the distance measure does not "discriminate" enough if the original columns are used. The positive entries in P range from the orders 10 −5 to 10 2 , and large values will have a dominating effect on the distance. As a result, only large deviations between two objects determine their dissimilarity and small entries are largely ignored. In IMRT, however, it is especially the many small contributions that add up to significant doses that can be exploited to shape the dose distribution. Therefore, a different characteristic for beamlets and cluster representatives must be found.
Better clusters can be expected when the information contained in the columns of P are condensed on an organ level. The contribution of a beamlet to a specific organ is given by the entries in the rows corresponding to voxels of that organ. From a statistics viewpoint, if these entries are seen as random variables, their moments suffice to characterize the beamlets. The kth moment of a random variable Y is given by the expected value of the kth power of Y , E Y k . We will characterize the beamlets and cluster representations by a vector of moments for each organ in the patient body. We limit the number of moments to at most 3, since higher moments are typically only of theoretical value [11, Chapter 3.9] . Thus, the vectors characterizing our objects only contain (number of organs × number of moments ≈ 10 to 20) entries and could look like the following if 2 moments are used:
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where the entry c s 1 h (i) denotes the hth moment of the contributions of beamlet i to the organ s 1 given by
The entries of the other organs are similar to (5) .
Now that we have decided on the dissimilarity measure for beamlets and cluster representatives, we need a method to group the beamlets into clusters. Because we fixed the number of clusters in Problem 2.1, we use the K-means algorithm 3.1 to aggregate the variables.
Algorithm 3.1 K-means algorithm adapted from [4]
Procedure: KM eans Input: Characteristic vectors c i , i = 1, . . . , n, number of clusters K, distance measure "dist" Output: allocation A
Step 1: Produce initial clusters 1, 2, . . . , K and allocation A and compute the cluster means µ 1 , . . . , µ K . Step 2: For beamlet i = 1, compute for every cluster k the increase in error in transferring this beamlet from cluster a(1) to cluster k given by
, where |k| denotes the cluster size of cluster k, and a(i) = {b : a ib = 1} denotes the cluster to which beamlet i is assigned to. If the minimum of this quantity over all k = a(i) is negative, transfer the beamlet i from cluster a(i) to this minimal k, adjust the cluster means of a(i) and k, and set a(i) := k.
Step 3: Repeat Step 2 for i = 2, . . . , n.
Step 4: If no movement of a beamlet from one cluster to another occurs, stop.
Otherwise, return to Step 2.
The characteristic vectors are the collections of moments of organ contributions, and the distance measure is the Euclidean. The cluster means are determined by adding the dose contributions of newly added or removed beamlets and is the most time-consuming operation of KM eans. Algorithm 3.1 is performed separately for each beam to ensure that exactly L clusters represent the beamlets of each direction. One method to obtain an initial clustering for Step 1 is to randomly assign beamlets to the K clusters. This also has the advantage that it produces different starting points for KM eans, each leading to a different locally optimal allocation. Typically the method runs fast enough so that the clustering can be performed several times with different starting points. The clustering with the smallest error is taken as the final aggregation. 
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Case 1: Artificial example
To demonstrate the basic effects of this type of variable aggregation, a simple, artificial case was created. Figure 4 shows one of the transversal slices of this case. The "body" is a large cube, and there are only three relevant structures. The cuboid at the bottom inside the body represents the tumor volume, and the other two structures resemble healthy organs. Five beam directions were chosen and the beamlets clustered to only 2 or 3 groups to illustrate the effect of this type of variable aggregation technique. The beamlets of the directions 0 and 288 degrees were grouped in 3 clusters, and the rest of the directions were clustered in 2 groups. As a result, the matrix P · A has only 12 columns, and about 36% of its entries are positive. Calculating the characteristic vectors for all beamlets and the clustering procedure took a total of about 2.4 seconds per beam on a 2.2 GHz processor. Figure 5(a) shows the cluster number of each beamlet in the intensity map corresponding to beam 0. It was surface of the beam can be parted in three: one area in the middle where both organs are in front of the tumor, and two areas where only one is in the way of the beam. Note that the clustering algorithm has no information about the location of the beamlets on the beam surface -they were clustered solely based on the information about their contributions to the structures. The other beam directions showed similar geometric back-projections. The clusters in beam 216 ( figure 5(d) ), for example, also resemble the projection of the structures on the beam: the area on the beam where only the farthest structure is hit constitutes a separate cluster of beamlets.
Case 2: Clinical prostate example
While the first artificial example demonstrates that the clustering method based on organ information is in principle capable of identifying different critical regions on the surface of the beam, this does not yet warrant a successful application to real cases. In this section, a prostate case is studied and the variables are aggregated. We will additionally formulate a treatment planning problem and compare the results from the original formulation with the solution to the aggregated problem. We delay the discussion of improving the aggregated solution until chapter 4. In this case, the prostate and the seminal vesicles are the target volumes. They compose the structure marked with the crosshairs in the left window of figure 6 . The structure in front of the prostate is the bladder, and behind the prostate, the rectal walls (anterior and posterior) are segmented separately. Finally, the femoral heads are also included as critical structures in this case to limit the dose absorbed by lateral beam directions.
BEAMLET CLUSTERING AND IMPLICATIONS
The dose information matrix consists of 799,200 rows and 173 columns. Again, 5 equiangular beam directions were chosen. There are 13,414,539 positive entries in P, which is 9.7% of all entries. The number of clusters was set to 4 for beam 0 and 5 for the rest. Determining the characteristics of all beamlets and aggregating them took a total of only 2 seconds per beam on a 2.2 GHz processor. The clusters are depicted in figure 7 . Again, the clusters closely resemble projections of the structures on the beam. In beam 0, for example, the beamlets corresponding to cluster 1 hit the prostate and both the anterior rectal wall and the posterior rectal wall. Cluster 2 are those beamlets where either only one or no rectal wall is hit. The beamlets in clusters 0 and 3, finally, have to shoot through the bladder and also hit both rectal walls behind the target. Cluster 0 hits the prostate and the beamlets in cluster 3 hit the seminal vesicles. Similar observations can be made for the other beam directions. As a result of the variable aggregation, P · A contains only 24 columns, and the percentage of positive entries increased to 17.6%.
To illustrate the loss in control we imposed, we now compare the original and aggregated solution to the following planning problem. The objective functions for the healthy structures are based on the equivalent uniform dose (EUD) concept [7]. They are of the form
where s denotes the corresponding organ, |s| is the number of voxels in that organ, 
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The objective functions for the tumor volumes are given by
to evaluate a lower bound for the target dose, and
with d hom slightly larger than d cur to ensure that the dose is homogeneous in the tumor volume.
The values for each parameter of the functions (6)- (8) The scalarized multicriteria optimization formulation to solve the treatment planning problem can now be stated:
Problem 3.1 (Scalarized treatment planning problem)
The constraints f cur (d), f hom (d) ≤ 0.5 on the tumor volumes largely prevent under-shooting d cur and exceeding d hom . There is no method to test a priori if these constraints can be met. In addition, we would like to use the solution to one aggregated problem as a starting solution for the next refined problem as described in the next chapter. That is, the solver used must be able to cope with infeasible as well as feasible iterates. For this reason, problem 3.1 is solved by a penalty sequential linear programming solver.
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One graphical output of the quality of a plan is the dose-volume histogram (DVH). These histograms display the percentage of a structure that receives at least a certain dose over the relevant dose interval. The DVH for the original problem is given in figure 8 . All calculations were done on the same 2.2 GHz processor to ensure comparability. The solver needed 23 minutes to obtain this solution. The DVH of the solution on the aggregated variables is depicted in 9 and the solver only needed 3 and a halve minutes. At first glance, it is obvious that the solution to the aggregated problem is not feasible. This may be expected as the degrees of freedom in the planning problem were severely reduced. However, there is a striking similarity in the DVH curves for the organs at risk in both histograms. The following It is, of course, not surprising that reducing the number of variables from 173 to only 24 may not produce feasible solutions. Some more variables in the planning problem are definitely needed. An iterative procedure to decide which variables to "free" for a subsequent optimization problem is the topic of the next chapter.
Adaptive control and refinement of clusters
In chapter 3, a method to aggregate the variables of the treatment planning problem was presented. In this section, we cover the refinement of variable clusters. It
ADAPTIVE CONTROL AND REFINEMENT OF CLUSTERS
16 is expected that the quality of a solution can deteriorate rather strongly or may not even be feasible when the number of clusters is small. Hence, a mechanism to break up existing clusters at stages in the algorithm must be implemented to improve the solution of an aggregated problem. Similar to the voxel clustering technique in [8] , we call such a method an adaptive refinement. In principle, the adaptive refinement creates a series of aggregated optimization problems starting from the first variable cluster, and successively breaks existing clusters in two child clusters. The treatment planning problem with the increased number of beamlet clusters is solved again and the objective function values are checked. An upper limit of how many variables can be freed this way serves as a stopping criterion. Of course, if the solution is still infeasible or the planner is not satisfied with this result, the procedure may be continued.
We will first introduce an idea to identify child clusters of existing aggregations based on the reference doses for each organ. Then we elaborate on how to control the iterations in the refinement. The prostate case of the previous chapter serves as a continuing illustration of the methods proposed in this chapter.
The critical question in a disaggregation procedure is which variables to free from existing clusters. We will make this decision based on the characteristics of the beamlets. In every iteration we identify one organ S that has an unfavorable dose distribution. Then all the clusters are searched and those beamlets with significant influence on the selected organ are separated into a new cluster. A limit on how many clusters are broken up this way is one of the control parameters of the refinement. To prevent moving too many beamlets into a single new cluster, the new clusters are constrained to contain only as many entries as the average cluster size of the old clusters. The procedure Ref inement Iteration is given in detail in algorithm 4.1.
In
Step 1 of each refinement iteration, the cluster errors regarding the target organ are evaluated and the worst clusters identified. These worst clusters all contain beamlets that could be used to better control the dose distribution in S. Those beamlets are identified in Step 2 of Ref inement Iteration and separated into new clusters. Since problem 3.1 demands to minimize the maximum EUD normalized by the reference doses, it is natural to pick that organ for which the maximum is attained as S.
The last choice that remains is how to choose the parameters of the refinement iteration. How many clusters should be formed in each iteration, and how many iterations should be done? One refinement iteration does not take much time because only the characteristic vectors of beamlets and clusters are compared. Each refined formulation of the treatment planning problem has to be resolved. The solution to the previous formulation should be an excellent starting point for the new problem and the refined solution should be found in a few solver iterations. Since this can all be achieved in little time, the number of clusters to be broken up in algorithm 4.1 can be set rather low -say 20 clusters over all beams. (2), . . .
Step 1: For each cluster k that hits S, compute the clustering error of target organ S given by h i∈k (c S h (i) − µ S h (k)) 2 h −1 , where h denotes the degree of the moment and rank the clusters in descending order of these errors.
Step 2: For the worst d clusters found, allocate all beamlets in those clusters that have a higher contribution to S than its cluster mean to a new cluster: n := 1 // counter for newly created clusters
= a(i) end if if cluster K + n contains more than t ave beamlets n := n + 1 end if next beamlet i next cluster k As there exists a lot of empirical evidence that not many degrees of freedom are necessary to produce treatment plans of good quality, the limit of how many variables to end the refinement procedure can be set rather low initially. A simple refinement strategy is then to choose a low threshold for the number of variables (say 60% of the number of beamlets). Once the number of variables is above this threshold, the refinement is only continued if the solution is not yet feasible.
We now illustrate the refinement strategy using the prostate case we began in the previous chapter. Starting from the solution in chapter 3, the refinement is carried out using the following rules: Rule 2 is included to avoid that on organ is refined too aggressively. The following The process stopped after about 18 and a halve minutes, and it took over 4 minutes less time than the original problem formulation. The DVH of the last refinement are shown in figure 10 . Perhaps the most striking difference is in the curves pertaining to the femoral heads and the anterior rectal wall. It is evident that the solution using the refinement strategy spared large parts of the anterior rectal wall at the cost of increasing the dose in the femoral heads. As the reference dose for these two organs is rather high compared to the realized dose, this has no effect on the objective function value. To compare, figure 11 displays the normalized EUD values for both, the original solution and the solution obtained from the last refinement.
DISCUSSION
19 Figure 11 : The objective function values (EUDs normalized by their reference doses) for the optimal solution found by the original problem formulation and by the last refinement. The maximum of the values for the optimal solution is obtained by the bladder, and the maximum of the objective function values for the last refinement is given by the value of the anterior rectal wall.
The objective function value for refinement 5 is even slightly better than the solution to the original formulation. This is because the solver stops if no significant improvement can be made for a long time. In the original formulation, the solver may have stopped too early. This shows that the clustering approach may also improve the convergence to the optimal solution.
As may be expected from the quality of the objective function values after the first clustered solution, the normalized EUD values did not change much over the solution process. However, the graphs in figure 12 shows that especially in the first two refinements the biggest improvement of the objective function values was attained by the organ which was refined in that step.
While the original solution took (25+20+20+22+22=) 109 apertures to be delivered, the solution to the last refinement problem took only (25+15+19+19+17=) 95. The number of monitor units, however, was the same at 216.
Discussion
In this work we introduced a variable aggregation technique for the treatment planning problem. The aggregation was motivated by a faster dose calculation that would speed up the solver iterations. A disaggregation method motivated by clinically meaningful indicators (i.e. the maximum EUD normalized by the reference dose) was developed to pose adaptively refined versions of the treatment planning Figure 12 : The improvements in the objective functions remained small over the solution process. However, larger improvements were realized for those organs which were chosen for the refinement.
problem. An example calculation on a clinical prostate case demonstrated the potentials of this method. The method introduced found a superior solution in less time. Due to the fact that some beamlets were still in clusters, the solution attained after clustering and refindement also needed significantly fewer shapes after sequencing. The success of this method supports the hypothesis that not all degrees of freedom have to be used to produced treatment plans of high quality.
